Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | GENB | ALMR | ||
| Company | Ra Pharmaceuticals Inc | Generate Biomedicines Inc | Alamar Biosciences Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.99 | 17.67 | 32.98 | ||
| High | 48.01 | 18.57 | 34.03 | ||
| Low | 47.98 | 17.38 | 32.95 | ||
| Last | 48.00 | 19.26 | 34.28 | ||
| Change | -0.02 | +1.54 | +1.58 | ||
| Percent Change | -0.03% | +8.69% | +4.83% | ||
| Volume | 3,864,600 | 304,820 | 12,237 | ||
| 20-Day Average Volume | 1,869,975 | 678,610 | 322,285 | ||
| Previous | 48.01 | 17.72 | 32.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 15.21 | 30.67 | ||
| 20-Day Raw Stochastic | 99.68% | 98.74% | 67.58% | ||
| 20-Day Relative Strength | 56.47 | 67.08 | 60.53 | ||
| Weighted Alpha | +21.70 | N/A | N/A | ||
| Today's Opinion | 56% Buy | N/A | N/A | ||
| Yesterday's Opinion | 56% Buy | N/A | N/A | ||
| Last Month's Opinion | 80% Buy | N/A | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | +14.99% since 08/18/26 | +1.96% since 08/18/26 | ||
| Low | 46.34 on 03/26/20 | 15.74 on 08/20/26 | 32.06 on 08/24/26 | ||
| High | 48.02 on 03/31/20 | 18.56 on 08/25/26 | 36.50 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | +37.99% since 07/24/26 | +29.85% since 07/24/26 | ||
| Low | 40.30 on 03/18/20 | 12.49 on 07/28/26 | 23.32 on 07/29/26 | ||
| High | 48.02 on 03/31/20 | 18.56 on 08/25/26 | 38.54 on 08/11/26 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | +27.25% since 05/22/26 | +67.52% since 05/22/26 | ||
| Low | 40.30 on 03/18/20 | 11.88 on 06/02/26 | 18.84 on 05/26/26 | ||
| High | 48.02 on 03/31/20 | 18.56 on 08/25/26 | 38.54 on 08/11/26 | ||
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | N/A since 02/27/26 | N/A since 04/17/26 | ||
| Low | 22.25 on 10/08/19 | 11.00 on 03/04/26 | 18.84 on 05/26/26 | ||
| High | 48.02 on 03/31/20 | 18.56 on 08/25/26 | 38.54 on 08/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 2,274,398 | 2,269,151 | ||
| Shares Outstanding, K | 47,329 | 128,352 | 69,393 | ||
| Annual Sales, $M | 3,000,000 | 31,890,000 | 74,210,000 | ||
| Annual Net Income, $M | -102,690,000 | -203,150,000 | -29,820,000 | ||
| Last Qtr Sales, $M | 3,000,000 | 6,310,000 | 29,430,000 | ||
| Last Qtr Income, $M | -24,980,000 | -67,260,000 | -13,200,000 | ||
| 60-Month Beta | 1.04 | N/A | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.52 on 08/06/26 | -0.22 on 08/10/26 | ||
| Latest Earnings Date | 05/14/20 | 11/05/26 | 11/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||